SINTER Study – Integrating Genotype and Phenotype to Understand Bone Fragility in Patients with Underlying Chronic Disease

How do your genes and lifestyle work together to shape your bone health? The SINTER Study is here to find out!
SINTER is an observational Recall-by-Genotype (RbG) study focused on skeletal fragility in individuals with chronic diseases. By combining genetic information (polygenic risk scores for bone mineral density) with in-depth musculoskeletal phenotyping, the study aims to uncover the biological and lifestyle factors contributing to bone fragility.
🧪 Stage 1: Blood samples and genetic profiling from 5,650 adults across eight Erasmus MC outpatient clinics:
Botcentrum, Diabetology, Center for Healthy Weight, Nephrology, Vascular Medicine, Thyroid Center, Geriatrics, and Mastocytosis.
🦴 Stage 2: From this group, 1,500 participants with genetically high or low bone density will be invited back for deep phenotyping. This includes DXA scans, full-body EOS imaging, bone and muscle strength testing, and lifestyle assessments.
Recruitment has already started in the Mastocytosis clinic, with other departments preparing to follow.
Ethical approval?✅ Secured!
The study is funded by the prestigious LEGENDARE Advanced Grant (No. 101021500), awarded to Prof. Fernando Rivadeneira.
For more information, visit our website: sinteronderzoek.nl